NCT01987167View on ClinicalTrials.gov

Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Optic Neuritis

Interventions

DRUG

ACTHAR

Injectable Gel

Trial Locations (1)

19107

Neuro Ophthalmology, Philadelphia

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Mallinckrodt

INDUSTRY

lead

Neuro-Ophthalmologic Associates, PC

OTHER

NCT01987167 - Defining the Functional and Neuro-Protective Potential of ACTHAR in Acute Optic Neuritis | Biotech Hunter | Biotech Hunter